BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2012
View Archived Issues
Parkinson's Disease Foundation awards grants to support research
Read More
First-in-human results show safety and immunogenicity of a novel AIDS vaccine
Read More
Researchers present results from taliglucerase alfa trials
Read More
Japanese researchers present novel GPR119 receptor agonists
Read More
Bionomics discloses new agents for CNS disorders
Read More
Merck & Co. patents novel dipeptidyl peptidase inhibitors
Read More
IRM discloses new Trk inhibitors
Read More
Phase III trial begins for theragnostic drug in patients with progressive midgut carcinoid
Read More
Baxter and Onconova enter into European licensing agreement for rigosertib
Read More
Intellikine divulges novel inhibitors of PI3Kalpha
Read More
Dompe presents new TRPM8 antagonists with potent activity in neuropathic pain models
Read More
Researchers at CSIC and the Universitat de Barcelona disclose new GSK-3 beta inhibitors
Read More
Belgian and U.S. researchers synthesize novel agents for viral infections
Read More
Urinary CCL18 assessed as a biomarker for Gaucher's disease
Read More
Bionor Pharma presents phase II results for HIV vaccine
Read More
Grifols updates on Alzheimer's disease research strategies
Read More
EB66 cell-based human influenza vaccine advances to phase III
Read More
Pharmacokinetic study of topical ketoprofen set to begin
Read More
Gamida Cell completes enrollment in phase I/II NiCord study
Read More
Phase II study begins of Zevalin in lymphoma
Read More
Health Canada approves Byetta added on to insulin glargine
Read More
Xcovery begins phase I/II trial of its angiogenesis inhibitor in wet AMD
Read More
Medivir and Janssen to conduct phase IIa trial of interferon-free combination for chronic HCV
Read More
Intellect Neurosciences and MRC Technology complete humanization of therapeutic antibody
Read More
Aerpio Therapeutics begins dosing in phase Ib/IIa trial of AKB-9778
Read More
PolyMedix receives NCI grant to study brilacidin for oral mucositis
Read More
Licensing agreement set after TXA-127 feasibility study
Read More
